Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Magna Investama Mandiri Tbk. (MGNA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Magna Investama Mandiri Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Magna Investama Mandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Magna Investama Mandiri Tbk. trades at Rp142 (market cap 463.91B, 244.26M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Magna Investama Mandiri Tbk. is far larger — about 2.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Magna Investama Mandiri Tbk. is more actively traded (244.26M versus 324K). Which is the better fit depends on your goals.

MGNAOBAT
Market Cap
463.91B166.01B
Volume
244.26M324K
Lot
2.44M3.24K
Turnover
40.48B77.68M
Average Price
165.72239.75
Value
40.48B77.68M
Indicative Equilibrium Price
142240
Indicative Equilibrium Volume
11.35K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MGNA
View details
OBAT
View details

About Magna Investama Mandiri Tbk.

PT Magna Finance Tbk (the Company) formerly PT Arkasa Utama Leasing was established based on Notarial Deed No. 10 dated March 09, 1984 of James Jacinta Susanti, S.H.

Read more on MGNA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT